HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Infectious Disease
Review of ESBL-producing E. coli epidemiology and fluoroquinolone resistance in Mexican community isolates
UTIs Are Getting Harder to Treat — Here’s Why
This retrospective cross-sectional study reviews community-acquired E. coli isolates from Mexico. Among 244 samples, 68% produced ESBL, with…
This could change how doctors choose antibiotics for UTIs.
medRxiv
Apr 23, 2026
Infectious Disease
FDA Approval
FDA Approves Cefepime for Injection and Dextrose Injection (cefepime) for Moderate to Severe Pneumonia and Other Infections
The FDA approved a new ready-to-use version of an antibiotic called cefepime for serious infections.
The FDA approved cefepime in a dextrose injection formulation for intravenous treatment of moderate to severe pneumonia, febrile neutropenia…
The FDA approved a ready-to-use antibiotic for serious infections like pneumonia and urinary tract infections in hospitalized patients.
FDA
Apr 10, 2026